![](/img/cover-not-exists.png)
917TiPPhase II study of paclitaxel and TAK-228 in metastatic urothelial carcinoma and the impact of PI3K-mTOR pathway genomic alterations
Rodríguez-Vida, A, Pérez-Gracia, J L, Taus, A, Bonfill, T, Vázquez-Mazón, F J, Galtes, S, Pons, B, Cano, L, Macia, S, Maroto, P, Bellmunt, JVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy283.126
Date:
October, 2018
File:
PDF, 83 KB
2018